Cannabis stocks rally on expectations of Trump move to ease curbs

Cannabis firms' US-listed shares rise between 5% and 20%

President Trump expected to sign an executive order to ease restrictions on Schedule I narcotic and deem it a less dangerous drug

Cronos Group CRON.O and Aurora Cannabis ACB.O rise 5.8% and 10%, respectively

Tilray Brands TLRY.O jumps 15.2% and Canopy Growth CGC.O surges 17.7%

Stocks have soared since reports emerged last week of Trump's plan to ease the curbs, which could ease reduce tax burdens and improve access to capital for the pot industry

Currently, marijuana, along with LSD and heroin, is a Schedule I controlled substance, meaning they have no currently accepted medical use and a high potential for abuse